STOCK TITAN

Acme United (NYSE: ACU) grows Q1 2026 sales but profits and debt worsen

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Acme United Corporation reported higher sales but lower profits for the quarter ended March 31, 2026. Net sales rose to $52.3 million from $46.0 million a year earlier, a 14% increase, or 6% growth excluding the My Medic acquisition.

Net income declined to $1.0 million, or $0.24 per diluted share, from $1.7 million, or $0.41 per diluted share, as higher cost of sales and operating expenses offset revenue gains. The company cited tariff-related costs, enhanced quality assurance spending at the Med-Nap facility, and rising employee healthcare costs as key drivers.

Acme highlighted contributions from the recently acquired My Medic business, which has annual sales of $19 million but minimal first-quarter profit due to seasonality. U.S., European, and Canadian segments all posted double-digit sales growth in U.S. dollars. Bank debt less cash increased to $38.6 million, reflecting the My Medic acquisition, a German product line purchase, dividends, a new Tennessee facility, and inventory builds to mitigate supply risks from the conflict in Iran.

Positive

  • Double-digit revenue growth: Net sales rose 14% year over year to $52.3 million, with 6% comparable growth excluding the My Medic acquisition and double-digit U.S., European, and Canadian segment increases.
  • Accretive growth initiatives underway: Acme completed the My Medic acquisition (with $19 million in annual sales), expanded its Spill Magic facility in Tennessee, and added a German cutting and sharpening product line to broaden its portfolio and capacity.

Negative

  • Earnings decline despite higher sales: Net income fell 40% to $1.0 million and diluted EPS dropped 41% to $0.24, as higher tariffs, quality assurance spending, and healthcare costs outweighed revenue gains.
  • Higher leverage and obligations: Bank debt less cash increased to $38.6 million from $27.2 million year over year, driven by acquisitions, capital spending for a new facility, dividends, and proactive inventory purchases.

Insights

Strong top-line growth is offset by sharply lower earnings and higher leverage.

Acme United delivered $52.3 million in Q1 2026 net sales, up 14% year over year, helped by acquisitions and solid first aid and medical product demand. All geographic segments showed double-digit sales gains in U.S. dollars.

Despite this, net income fell 40% to $1.0 million and diluted EPS declined 41% to $0.24 as tariff-related costs, quality investments at the Med-Nap facility, and higher healthcare expenses pushed selling, general and administrative expenses up significantly.

Bank debt less cash climbed to $38.6 million by March 31, 2026, reflecting the My Medic acquisition, a German product line purchase, a new Tennessee facility, and proactive inventory builds tied to geopolitical risks. Future filings will show whether these investments translate into improved profitability, particularly in My Medic’s seasonally stronger fourth quarter.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Net sales $52.3 million Quarter ended March 31, 2026; up 14% from $46.0 million
Net income $1.0 million Quarter ended March 31, 2026; down from $1.7 million
Diluted EPS $0.24 per share Quarter ended March 31, 2026; vs. $0.41 prior year
Gross margin 39.7% Q1 2026 gross margin vs. 39.0% in Q1 2025
Bank debt less cash $38.6 million As of March 31, 2026; vs. $27.2 million a year earlier
My Medic purchase price $18.7 million Assets acquisition; $14.6 million paid net of $4.1 million holdbacks
German product line purchase $1.6 million Cutting and sharpening products acquired in Germany
Free cash flow $14.2 million Generated in twelve months ended March 31, 2026, before $6.0M facility purchase
free cash flow financial
"the Company generated approximately $14.2 million in free cash flow, before the purchase"
Free cash flow is the amount of money a company has left over after paying all its expenses and investing in its business, like buying equipment or updating facilities. It shows how much cash is available to reward shareholders, pay down debt, or save for future growth. This helps investors understand if a company is financially healthy and able to grow.
operating lease right of use asset financial
"Operating lease right of use asset | | | 6,408 | | | | | 4,443"
forward-looking statements regulatory
"The Company may from time to time make written or oral “forward-looking statements”"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
gross margin financial
"Gross margin was 39.7% in the first quarter of 2026 versus 39.0%"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
bank debt less cash financial
"The Company’s bank debt less cash as of March 31, 2026 was $38.6 million"
operating income financial
"Operating income | | | 1,746 | | | | | 2,426"
Operating income is the profit a company earns from its regular business activities after subtracting the costs directly related to running the business, such as wages, rent, and supplies. It shows how well the core operations are performing, ignoring income or expenses from non-regular activities like investments or one-time events. Investors use it to assess the company's efficiency and profitability from its main work.
Offering Type earnings_snapshot
0000002098false00000020982026-04-232026-04-23

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): April 23, 2026

 

ACME UNITED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Connecticut

001-07698

06-0236700

(State or other jurisdiction

of incorporation or organization)

(Commission file number)

(I.R.S. Employer

Identification No.)

1 Waterview Dr, Shelton, Connecticut

 

06484

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (203) 254-6060

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $2.50 par value per share

 

ACU

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On April 23, 2026, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this current report.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(c) Exhibits

 

Exhibit

Number

Description

99.1

Press release dated April 23, 2026.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ACME UNITED CORPORATION

 

By

/s/ Walter C. Johnsen

Walter C. Johnsen

Chairman and

Chief Executive Officer

Dated: April 23, 2026

By

/s/ Paul G. Driscoll

Paul G. Driscoll

Vice President and

Chief Financial Officer

Dated: April 23, 2026

 

 


Ex 99.1

 

ACME UNITED CORPORATION NEWS RELEASE

CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484

Phone: (203) 254-6060

 

FOR IMMEDIATE RELEASE April 23, 2026

 

 

ACME UNITED REPORTS

FIRST QUARTER 2026 FINANCIAL RESULTS

 

SHELTON, CT – April 23, 2026 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2026 were $52.3 million compared to $46.0 million for the quarter ended March 31, 2025, an increase of 14%. Excluding incremental sales resulting from the acquisition of the assets of My Medic on January 15, 2026, comparable sales increased 6%.

 

Net income was $1.0 million, or $0.24 per diluted share, for the quarter ended March 31, 2026, compared to $1.7 million, or $0.41 per diluted share, for the comparable period last year, a decrease of 40% in net income and 41% in diluted earnings per share. This decrease was due to higher cost of sales and increased operating expenses primarily as a result of higher tariff-related costs and investments in enhanced quality assurance protocols at the Med-Nap facility, together with rising employee healthcare expenses. Tariff expenses were recognized during the first quarter as the company sold inventory that had been subject to higher tariff rates imposed in 2025.

 

The recently acquired My Medic business, which sells tactical, trauma and emergency response products directly to consumers, contributed to sales growth, with minimal impact on earnings in the first quarter. As a direct-to-consumer seasonal business, My Medic is expected to generate the majority of its profitability in the fourth quarter.

 

Chairman and CEO, Walter C. Johnsen said, “While we experienced higher costs of sales and operating expenses in the first quarter, the impact was magnified due to the seasonality of our business, which traditionally has lower sales in the first quarter. We are actively working to improve profitability. We just moved into our new Spill Magic facility in Tennessee- in the process lowering expenses and providing room to expand;

1

 


Ex 99.1

consolidated one of our sites in Canada; and are continuing to install automation throughout our facilities. My Medic, which has annual sales of $19 million, offers many compelling growth and cost saving opportunities. We are expanding My Medic’s retail distribution while also leveraging Acme United’s strong purchasing network to reduce costs, cutting overhead, and consolidating functions. Importantly, the expenses incurred for the enhanced quality assurance protocols at the Med-Nap facility were one-time, non-recurring expenses.”

 

Mr. Johnsen continued, “We have been proactively purchasing additional inventory in preparation for product shortages and cost increases resulting from the conflict in Iran. To date, we have added approximately $10 million of incremental orders for delivery in the second and third quarters and are carefully evaluating additional purchases.”

 

Mr. Johnsen concluded, “Acme United has extensive experience with supply chain challenges, and I am confident that our team will address them successfully. I also believe the investments we have been making in expanding Acme United’s business lines, technology, and capacity will continue to strengthen our Company.”

 

For the first quarter of 2026, net sales in the U.S. segment increased 12% compared to the same period in 2025 due to increased sales of first aid and medical products and additional sales resulting from the acquisition of My Medic.

 

European net sales for the first quarter of 2026 increased 32% in U.S. dollars and 19% in local currency compared to the first quarter of 2025 due primarily to higher ecommerce sales and additional sales resulting from the acquisition of the line of cutting and sharpening products in Germany on October 1, 2025.

 

Net sales in Canada for the first quarter of 2026 increased 16% in U.S. dollars and 11% in local currency compared to the same period in 2025 due to higher sales of first aid products.

 

Gross margin was 39.7% in the first quarter of 2026 versus 39.0% in the comparable period last year.

2

 


Ex 99.1

 

The Company’s bank debt less cash as of March 31, 2026 was $38.6 million compared to $27.2 million as of March 31, 2025. During the twelve-month period ended March 31, 2026, the Company paid approximately $14.6 million for the acquisition of the assets of My Medic ($18.7 million purchase price less $4.1 million of holdbacks), distributed approximately $2.4 million in dividends on its common stock and purchased the cutting and sharpening line of products in Germany for approximately $1.6 million. Additionally, the Company generated approximately $14.2 million in free cash flow, before the purchase for cash of a new $6.0 million manufacturing and distribution facility in Tennessee in July 2025 to expand the Company’s Spill Magic business.

Conference Call and Webcast Information

Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Thursday, April 23, 2026, at 12:00 p.m. ET. To listen or participate in a question-and-answer session, dial 877-407-0784. International callers may dial 201-689-8560. The confirmation code is 13759878. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.

 

About Acme United

ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Pac-Kit®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap®, Elite First Aid® and My Medic®. For more information, visit www.acmeunited.com.

 

Forward Looking Statements

 

The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs

3

 


Ex 99.1

as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.

 

Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results.

 

These risks and uncertainties include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of volatility in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) international trade policies of the United States or foreign governments and their impact on demand for our products and our competitive position, including the imposition of new tariffs, changes in existing tariff rates or the threat of any such action; (iv) the continuing adverse impact of inflation, including product costs, and interest rates; (v) potential adverse effects on the Company, its customers, and suppliers resulting from the conflicts in Ukraine and the Middle East; (vi) additional disruptions in the Company’s supply chains, whether caused by pandemics, natural disasters, including trucker shortages, strikes, port closures or otherwise; (vii) labor related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (viii) currency fluctuations; (ix) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (x) changes in client needs and consumer spending habits; (xi) the impact of competition; (xii) the impact of technological changes including, specifically, the growth of online marketing and sales activity; and (xiii) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

 

4

 


Ex 99.1

# # #

 

ACME UNITED CORPORATION

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

 

FIRST QUARTER REPORT 2026

 

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Quarter Ended

 

 

 

Quarter Ended

 

Amounts in $000's except per share data

 

March 31, 2026

 

 

 

March 31, 2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

$

 

52,301

 

 

 $

 

45,958

 

Cost of goods sold

 

 

31,516

 

 

 

 

28,041

 

Gross profit

 

 

20,785

 

 

 

 

17,917

 

Selling, general and administrative expenses

 

 

19,039

 

 

 

 

15,491

 

Operating income

 

 

1,746

 

 

 

 

2,426

 

Net interest expense

 

 

485

 

 

 

 

397

 

Other expense (income), net

 

 

17

 

 

 

 

(90

)

Income before income tax expense

 

 

1,244

 

 

 

 

2,119

 

Income tax expense

 

 

259

 

 

 

 

466

 

Net income

$

 

985

 

 

 $

 

1,653

 

 

 

 

 

 

 

 

 

Shares outstanding - basic

 

 

3,808

 

 

 

 

3,754

 

Shares outstanding - diluted

 

 

4,156

 

 

 

 

4,065

 

 

 

 

 

 

 

 

 

Earnings per share - basic

$

 

0.26

 

 

$

 

0.44

 

Earnings per share - diluted

 

 

0.24

 

 

 

 

0.41

 

 

 

 

 

 

 

 

 

 

 

 

5

 


Ex 99.1

ACME UNITED CORPORATION

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

FIRST QUARTER REPORT 2026

 

(Unaudited)

 

 

 

 

 

 

 

 

 

Amounts in $000's

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2026

 

 

 

March 31, 2025

 

Assets

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

 

4,196

 

 

$

 

3,446

 

Accounts receivable, net

 

 

33,511

 

 

 

 

30,814

 

Inventories

 

 

63,386

 

 

 

 

57,274

 

Prepaid expenses and other current assets

 

 

4,518

 

 

 

 

5,311

 

Total current assets

 

 

105,611

 

 

 

 

96,845

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

39,295

 

 

 

 

32,153

 

Operating lease right of use asset

 

 

6,408

 

 

 

 

4,443

 

Intangible assets, less accumulated amortization

 

 

34,021

 

 

 

 

19,690

 

Goodwill

 

 

9,908

 

 

 

 

9,908

 

Total assets

$

 

195,243

 

 

$

 

163,039

 

 

 

 

 

 

 

 

 

Liabilities and stockholders' equity

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable

$

 

7,654

 

 

$

 

7,433

 

Operating lease liability - short term

 

 

1,373

 

 

 

 

1,533

 

Mortgage payable - short term

 

 

458

 

 

 

 

441

 

Other current liabilities

 

 

13,620

 

 

 

 

10,662

 

Total current liabilities

 

 

23,105

 

 

 

 

20,069

 

 

 

 

 

 

 

 

 

Long-term debt

 

 

33,030

 

 

 

 

20,428

 

Mortgage payable - long term

 

 

9,362

 

 

 

 

9,769

 

Operating lease liability - long term

 

 

5,177

 

 

 

 

3,012

 

Other non-current liabilities

 

 

7,841

 

 

 

 

1,480

 

Total liabilities

 

 

78,515

 

 

 

 

54,758

 

Total stockholders' equity

 

 

116,728

 

 

 

 

108,281

 

Total liabilities and stockholders' equity

$

 

195,243

 

 

$

 

163,039

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 


FAQ

How did Acme United (ACU) perform financially in Q1 2026?

Acme United grew net sales to $52.3 million in Q1 2026, up 14% from $46.0 million a year earlier. However, net income declined to $1.0 million from $1.7 million as higher costs and expenses offset the strong revenue growth.

Why did Acme United’s Q1 2026 earnings decline despite higher sales?

Earnings fell because costs rose faster than sales. Higher tariff-related expenses, investments in enhanced quality assurance at the Med-Nap facility, and increased employee healthcare costs drove operating expenses up, reducing net income and diluted earnings per share versus last year.

What impact did the My Medic acquisition have on Acme United’s Q1 2026 results?

The My Medic acquisition boosted net sales and is included in the 14% growth figure. Management noted My Medic had minimal first-quarter earnings impact due to its direct-to-consumer seasonality, with most profitability expected in the fourth quarter each year.

How did Acme United’s regional segments perform in Q1 2026?

In Q1 2026, U.S. segment sales grew 12%, driven by first aid and medical products and My Medic. European net sales increased 32% in U.S. dollars, 19% in local currency, and Canadian sales rose 16% in U.S. dollars, 11% in local currency, mainly from first aid demand.

What is Acme United’s debt position as of March 31, 2026?

As of March 31, 2026, Acme United’s bank debt less cash was $38.6 million, up from $27.2 million a year earlier. The increase reflects funding for the My Medic acquisition, a German product line purchase, a new Tennessee facility, dividends, and inventory builds.

Filing Exhibits & Attachments

2 documents